Home Test Kits | Home | Contact Us | Links




ABO Blood Group System ABO Mismatched Allogeneic Transplants Albumin Autoimmune Hemolytic Guidelines Blood Administration Blood Component Transfusion Guidelines Blood Donation CMV Negative Blood Components Compatibility Testing Cryoprecipitate Factor IX Complex Factor VIIa Factor VIII Concentrate Factor VIII Inhibitors Fresh Frozen Plasma Granulocyte Transfusion Hemolysis Following Allogeneic BMT Informed Consent Irradiated Blood Components Leukocyte Reduced Red Cells & Platelets Massive Transfusion Neonatal Alloimmune Thrombocytopenia Nitric Oxide Banked Blood Other Blood Group Systems Pediatric & Neonatal Transfusion Practices Platelet Transfusion Prenatal & Perinatal Immunohematologic Testing RBC Transfusion Trigger Red Blood Cell Transfusion Rh Blood Group System RhIG for HDN Prevention RhIG for Treatment of ITP Saline Washed Red Blood Cells Sickle Cell Disease Transfusion Therapeutic Apheresis Thrombotic Thrombocytopenic Purpura Transfusion Reactions Transfusion Related Acute Lung Injury Trypanosoma Cruzi Donor Screening Umbilical Cord Blood Stem Cells von Willebrands Disease Warm Autoimmune Hemolytic Anemia

Albumin

Albumin comprises 60% of the total serum protein and 60 to 80% of colloid osmotic pressure. Serum albumin is synthesized solely by the liver and has several physiological functions: transport of low molecular weight substances such as calcium, hormones, and drugs; binding of toxic heavy metal ions; maintenance of colloid osmotic pressure; and provision of a protein reserve. Normally, about 4% of the total body albumin is replenished each day. The rate of production is dependent on the supply of amino acids, plasma oncotic pressure, inhibitory cytokines (especially IL-6) concentration, and the number of functioning hepatocytes. Circulating half-life of plasma albumin is 19 to 21 days.

Plasma albumin levels are low in neonates, typically between 2.8 and 4.4 g/dL. Adult levels are reached after the first week of life. Levels are slightly higher in children (4.5 - 5.5 g/dL) between the age of 6 years and young adulthood. Thereafter, levels decline to typical adult levels. Albumin levels show a downward trend throughout pregnancy and with aging, especially after age 70. Serum albumin levels are normally lower in hospitalized than ambulatory patients. Albumin levels can decrease as much as 1 g/dL after a patient becomes recumbent. Albumin concentration may decrease after crystalloid infusion or in patients with fluid retention. Falsely low values will be obtained if a blood sample is drawn above an IV site.

Hypoalbuminemia can be caused by many different disease states. The main causes include:

Protein loss (nephrotic syndrome, burns, protein losing enteropathy)
Increased albumin turnover (infections, other catabolic states, glucocorticoids)
Decreased protein intake (malnutrition, very low protein diet)
Liver disease

Plasma albumin is seldom decreased in acute hepatitis, because of its long circulating half-life. Decreased serum albumin usually indicates liver disease of more than 3 weeks duration. Albumin is a good indicator of decompensation and prognosis in cirrhosis.

Albumin is a good marker for chronic protein calorie malnutrition, but not for short term protein deprivation. Hypoalbuminemia is associated with poor surgical outcome and increased length of stay. Serum albumin levels less than 2 g/dL are associated with a 60% thirty-day mortality rate.

Abnormally high albumin levels are seldom clinically important. Increased serum albumin levels are seen only with dehydration or after excessive albumin infusion. Artefactual causes of high levels include specimen evaporation and prolonged use of a tourniquet during venipuncture.

Reference range is 3.6 - 4.6 gm/dL (Vitros Analyzer).

Specimen requirement is one SST tube of blood.